Lifting the Burden of Cardiovascular Disease and Diabetes

Watch the above introductory video to review the curriculum


Click on a topic below to begin:

TCT 2016

Discuss With The Experts: Title TBD
(0.50 CME/CNE credits)

TCT 2016

Perspectives on the Interplay of CVD and DM: A Discussion between Diabetic and Cardiovascular Experts
(0.50 CME/CNE credits)

TCT 2016

Discuss with the Experts: Combining Therapies: Questions and Issues that Arise (1st offering)
(0.50 CME/CNE credits)

TCT 2016

Discuss with the Experts: Is Tailoring Treatment the Best Approach to Care?
(0.50 CME/CNE credits)

TCT 2016

DM and CVD: Efforts in Cross Disciplinary Communication
(0.50 CME/CNE credits)

TCT 2016

Educating Patients on T2DM Pharmacotherapies
(0.25 CME/CNE credits)

TCT 2016

Patient Interactive: A Conversation with an Acute Patient
(0.50 CME/CNE credits)

TCT 2016

Patient Interactive: A Conversation with a Chronic Patient
( 0.50 CME/CNE credits)

TCT 2016

ACC CardiaCast: Emerging Data in SGLT2 Inhibitors
Opens: TBD Closes TBD
( 0.25 CME/CNE credits)

TCT 2016

Compare and Contrast the Use of SGLT2 Inhibitors and GLP1 Agonists: A Case Study
(0.50 CME/CNE credits)

TCT 2016

ACC CardiaCast: Risk-Benefit Analysis and Dosing
(0.25 CME/CNE credits)

TCT 2016

ACC CardiaCast: Intensifying and Altering Medical Therapies
(0.25 CME/CNE credits)

TCT 2016

Cardio-Protective Properties of DM Pharmacotherapies: A Case Study
(0.50 CME/CNE credits)

TCT 2016

Discuss with the Experts: Article Review: Emerging Evidence Regarding the Co-Morbidities and Cardio-Protective Properties of DM Pharmacotherapy (1st offering)
(0.50 CME/CNE credits)

TCT 2016

ACC CardiaCast: Examining DM Pharmacotherapy and CVD Co-Morbidities
(0.25 CME/CNE credits)

TCT 2016

ACC CardiaCast: The Cardio-Protective Nature of DM Pharmacotherapies
(0.25 CME/CNE credits)

TCT 2016

Discuss with the Experts: Combining Therapies: Questions and Issues that Arise (2nd offering)
(0.50 CME/CNE credits)


Target Audience

This activity is primarily intended for general adult cardiologists and the cardiovascular care team (nurse practitioners, registered nurses, physician assistants and pharmacists). Endocrinologists and primary care physicians may also benefit from this education.

Learning Objectives

Upon completion of one or more activities proposed, learners should be able to:

    1. Compare the disproportionate CV morbidity and mortality risks in patients with diabetes vs patients without T2D.
    2. Differentiate various T2D pharmaceutical therapies with respect to cardiovascular outcomes.
    3. Analyze current and emerging evidence from clinical trials focused on the management of high risk patients with CV-related comorbidities.
    4. Evaluate effective treatment options for patients with T2D and CV disease spanning lifestyle modifications, prevention strategies for dyslipidemia, smoking, obesity, hypertension, and pharmaceutical management for glucose control.

 

Each activity offers the credit amounts listed above. After completing the evaluation for each activity, the option to claim CME/CNE/MOC will appear. A Certificate of Participation is also available.

Learners will be guided through three stages of learning (review, innovate and lead), detailed below.

Review

Learners will be introduced to material through expert perspective and expert dialogue videos and will be given the opportunity to discuss in moderated format, as well as on their own, topics related to the material.  Learners will also be given access to faculty via virtual office hours, and will be given the opportunity to ask questions pertaining to the covered topics or current and related treatment issues they are facing.

Innovate 

Learners will be introduced to material through a variety of podcasts and will be given the opportunity to apply new knowledge through case-studies and branching scenarios, as well as discuss emerging and new clinical trial data and treatment options with peers and experts in a moderated discussion topic forum. 

Lead 

Learners will be asked to demonstrate an understanding of patient education tactics in relation to diabetes mellitus and cardiovascular disease treatment as well as will be charged with patient lifestyle change advocacy.

Learners will be introduced to material through expert perspective videos and will be given the opportunity to apply new knowledge through participation in interactive case-based scenarios videos.

Please clear your browser history and try logging in again. If you are still having trouble, please contact the Resource Center by calling (800)253-4636, ext. 5603 or (202) 375-6000, ext. 5603 or email us at resource@acc.org.

You do have to login to be able to access this content. If you do not have an account, please create one here:

Create an account

If you create an account, please make sure to login before viewing this course.

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC. and Novo Nordisk Inc.